American Board of Optometry

06/04/2026

Calling all third- and fourth-year optometry students! ABO's annual Learning Through Clinical Care case contest opens June 15th. Scan the QR code for details and get your case ready to submit!

05/29/2026

According to the CTCAE, when dry eye signs are noted clinically but the patient is asymptomatic, the dry eye is a Grade 1. For additional reading, see the following reference from ABO’s 2024 Learning Through Clinical Care Student Case Report Contest.:

Dao, Jeanetta. Ocular Adverse Effects of Tivdak® Infusion Therapy.
https://americanboardofoptometry.org/wp-content/uploads/2025/01/Jennetta-Dao-ABO-Clinical-Case-Report.pdf

05/26/2026

Third question in this series! Leave your answer in the comments and check back tomorrow!

05/21/2026

Did you answer correctly?

According to the CTCAE, a keratitis that is symptomatic with moderate decrease in VA (no more than a 3 line decrease from baseline VA) is considered Grade 2 keratitis.

For additional reference: Dao, Jeanetta. Ocular Adverse Effects of Tivdak® Infusion Therapy. Winner of ABO’s 2024 Learning Through Clinical Care Student Clinical Case Report Contest.https://americanboardofoptometry.org/wp-content/uploads/2025/01/Jennetta-Dao-ABO-Clinical-Case-Report.pdf

05/20/2026

Leave your answer in the comments and check back tomorrow for the correct response!

05/11/2026

Still time to register! Don't miss this free webinar with ABO Diplomate Steven Sorkin, OD, in collaboration with Harrow, Inc. To register visit: https://attendee.gotowebinar.com/register/6523383151373957468

05/07/2026

Don't miss ABO's Spring/Summer newsletter! Dr. Cathy Hines announces retirement, Dr. David Parker named AOA's 2026 Optometrist of the Year, and an educational collaboration with Harrow, Inc. Read these stories and more!

As our annual meeting approaches next month, we’re excited to look ahead and focus on ABO’s successes and ways we’re continuing to connect with colleagues across the profession.

05/05/2026

Don't miss this special webinar event in collaboration with Harrow, Inc., featuring Steven Sorkin, OD! To register visit:

https://attendee.gotowebinar.com/regi.../6523383151373957468

04/30/2026

Don't miss this special webinar event in collaboration with Harrow, Inc., featuring Steven Sorkin, OD! To register visit:
https://attendee.gotowebinar.com/register/6523383151373957468

04/24/2026

Following a comprehensive baseline examination prior to initiating Tivdak therapy, an anterior segment evaluation is conducted prior to each subsequent dose, usually administered every 3 weeks. For additional reading, visit:
https://americanboardofoptometry.org/wp-content/uploads/2024/08/Jennetta-Dao-1st-Place-Case.pdf